Concepedia

Hongrui Xu

HX

10

Publications

219

Citations

10

H-Index

2011

Active since

Affiliations

Guangzhou Institutes of Biomedicine and Health(Current)

Chinese Academy of Sciences

State Key Laboratory of Respiratory Disease

Guangzhou Medical University

University of Chinese Academy of Sciences

Hongrui Xu is an author at Guangzhou Institutes of Biomedicine and Health specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2024

10

Publications

10

Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir

Xiaoxin Chen, Xiaodong Huang, Qinhai Ma et al. · Nature Microbiology · 2024 · 61 citations · Full text

Structure-Based Discovery and Optimization of Furo[3,2-<i>c</i>]pyridin-4(5<i>H</i>)-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors

Junhua Li, Cheng Zhang, Hongrui Xu et al. · Journal of Medicinal Chemistry · 2022 · 27 citations · Full text

Spatial features for Escherichia coli genome organization

Ting Xie, Liang-Yu Fu, Qingyong Yang et al. · BMC Genomics · 2015 · 25 citations · Full text

Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia

Wenhua Jiang, Qiangqiang Hou, Hongrui Xu et al. · Journal of Medicinal Chemistry · 2024 · 22 citations · Full text

An evaluation of the protective effects of chlorogenic acid on broiler chickens in a dextran sodium sulfate model: a preliminary investigation

Yueping Chen, Pingping Zha, Hongrui Xu et al. · Poultry Science · 2022 · 16 citations · Full text

Rows per page

1–5 of 10